RT @HJWesteneng
1/ Using data of different #COVID19 variants from 42 countries in a multilevel multinomial model I compared the growth advantage of these variants.

The estimated growth advantage of Omicron compared to Delta (B.1.617.2) is 245%/week (95% credible interval: 205-297%).